UNSPSC 51201702: E Coli vaccines

This clasification denotes vaccines or candidate vaccines used to prevent or treat infections from a species of gram-negative, facultatively anaerobic, rod-shaped bacteria (gram-negative facultatively anaerobic rods) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce diarrhea and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins ( enterotoxigenic escherichia coli), etc.

UNSPSC 51201702 E Coli vaccines is a Commodity code that encompasses state and local procurement of bacterial vaccines, though recent posted opportunities show substantial divergence from the code's nominal scope. The Mississippi State Department of Health posted a sole source notice for Yellow Fever Vaccine from Sanofi Pasteur on July 13, 2026, with an objection deadline of August 3, 2026 at 10:00 a.m. CST — a vaccine unrelated to E. coli pathogens. State health departments drive procurement under this code, sourcing vaccines for routine immunization programs and public health campaigns. The notice structure reflects state procurement law: objections to sole source designation are invited, and if substantiated challenges to exclusivity are received, the department must either withdraw the sole source classification and conduct a competitive bid or appeal to the state Public Procurement Review Board to establish that no alternative vendor exists.

The single recent opportunity identified does not represent typical E. coli vaccine procurement activity; it reflects a misfiled or mis-coded notice within the state and local data. Quantity, contract term, estimated value, and pricing are not disclosed in the Yellow Fever Vaccine notice. The code shows minimal recent activity in the most-recent-state-local-contract-opportunities block, and the one entry posted does not align with the E. coli vaccine scope the code's name suggests. State and local procurement under UNSPSC 51201702 may warrant monitoring, but the available public record offers no clear signal of active demand for E. coli vaccines or of regular competitive solicitation patterns in this Commodity category at this time.